Authors proposed that osteopontin is crucial in women postmenopausal osteoporosis and that approaches trying to diminish the action of osteopontin may show effectiveness in overcoming osteoporosis (Yoshitake et al., 1999). Here, SPP1 is linked to postmenopausal osteoporosis.